CureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ... [Yahoo! Finance]
CureVac N.V. - Ordinary Shares (CVAC)
Company Research
Source: Yahoo! Finance
Net Profit: EUR371.6 million for the third quarter, EUR229.4 million for the first nine months of 2024. Cash Position: EUR550.9 million at the end of the third quarter. Licensing Agreement: EUR400 million upfront payment from GSK, fully recognized as revenue in Q3 2024. Operating Profit: EUR368.4 million for the third quarter, EUR221.4 million for the first nine months of 2024. Workforce Reduction: 30% reduction by the end of 2024, expected to decrease operational expenses by over 30% starting in 2025. R&D Expenses: Increased due to higher investments in oncology development programs and litigation expenses. General and Administrative Expenses: Decreased due to lower personnel expenses. Warning! GuruFocus has detected 5 Warning Signs with CVAC. Release Date: November 12, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript CureVac NV ( NASDAQ:CVAC ) secured a new licensing agreement valued at up to EUR 1.45 billi
Show less
Read more
Impact Snapshot
Event Time:
CVAC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CVAC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CVAC alerts
High impacting CureVac N.V. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
CVAC
News
- Is the Options Market Predicting a Spike in CureVac (CVAC) Stock? [Yahoo! Finance]Yahoo! Finance
- Is CureVac N.V. (CVAC) the Best German Stock to Buy Now? [Yahoo! Finance]Yahoo! Finance
- CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update Accesswire
- CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024Accesswire
CVAC
Sec Filings
- 11/12/24 - Form 6-K
- 11/12/24 - Form 6-K
- 11/4/24 - Form 6-K
- CVAC's page on the SEC website